You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
BETHESDA, Md. — The beleaguered state of biomarker research was once again a topic of discussion at this week’s annual conference of the US Human Proteome Organization, held here this week.
With many proteomics experiments now largely fishing for biomarkers, the field is increasingly looking inward to reflect on where the research is and concluding that for all the work that has been done, it has fallen short of expectations.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.
Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.
The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.
In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.